title: Effect of high-molecular-weight sodium hyaluronate on immobilized rabbit knee.
abstract: Experimental osteoarthrosis of the knee joint was induced in rabbits using a polyethylene binding brace. A 1% solution of sodium hyaluronate (HA) of molecular weight 1.73 x 10(6) (HA-173) was administered intraarticularly at a dosage of 0.1 ml/kg body weight twice a week. Changes in articular cartilage and synovial membrane, and joint contracture were compared with a saline control group at intervals throughout a six-week period of immobilization. In all groups, articular cartilage degeneration and joint contracture progressed with time but were inhibited by the administration of HA-173. Additionally, the results of a 1% solution of HA of molecular weight 9.8 x 10(5) (HA-98), a 1% solution of HA of molecular weight 2.02 x 10(6) (HA-202), and saline, each administered twice a week for five weeks at a dose of 0.1 ml/kg body weight, were compared. It was clear that the articular cartilage degeneration was significantly inhibited by HA as compared with saline, and that the effect was more potent with the higher molecular weight, HA-202, than with HA-98. Furthermore, joint contracture was inhibited by HA, and the effect was more potent with the higher molecular weight, HA-202, than with HA-98.
authors.affiliation: Department of Orthopaedic Surgery, Tokyo Kouseinenkin Hospital, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Sakakibara
authors.forename: T
authors.initials: T
authors.lastname: Miura
authors.forename: H
authors.initials: H
authors.lastname: Iwata
authors.forename: T
authors.initials: T
authors.lastname: Kikuchi
authors.forename: T
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: T
authors.initials: T
authors.lastname: Yoshimi
authors.forename: H
authors.initials: H
authors.lastname: Itoh
mesh_terms: D000818:Animals; D001915:Braces; D002358:Cartilage, Articular / Q000187:drug effects / Q000473:pathology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D007103:Immobilization; D007719:Knee Joint / Q000187:drug effects* / Q000473:pathology; D008297:Male; D008970:Molecular Weight; D010003:Osteoarthritis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D011095:Polyethylenes; D011817:Rabbits; D013583:Synovial Membrane / Q000187:drug effects / Q000473:pathology; D013997:Time Factors
chemical_list: D011095:Polyethylenes; D006820:Hyaluronic Acid